GlaxoSmithKline 4Q13 4Q Revenues: £6.9 billion (+2%) 4Q Earnings: £2.5 billion (+205%) FY Revenues: £26.5 billion (flat) FY Earnings: £5.6 billion (+20%) Comments: Sales of Pharmaceuticals and Vaccines (P&V) rose 6% in 4Q to £5.7 billion, and were up 1% for FY to £21.3 billion. Consumer Healthcare sales were flat at £1.2 billion for 4Q and up 2% to £5.3 billion for FY. Respiratory revenues were up 7% (CER) to £2.0 billion in 4Q and up 4% to £7.5 billion in FY, driven by increases in Ser...